Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating, chronic neuromuscular and neurological diseases, provided an update on certain impacts of COVID-19 on its business operations.
April 8, 2020
· 7 min read